TMED vs. TDVG
TMED (T. Rowe Price Health Care ETF) and TDVG (T. Rowe Price Dividend Growth ETF) are both exchange-traded funds - TMED is a Health & Biotech Equities fund managed by T. Rowe Price, while TDVG is a Large Cap Growth Equities fund actively managed by T. Rowe Price. Over the past year, TMED returned 36.59% vs 17.04% for TDVG. A 0.56 correlation means they provide meaningful diversification when combined. TMED charges 0.44%/yr vs 0.50%/yr for TDVG.
Performance
TMED vs. TDVG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TMED achieves a 15.07% return, which is significantly higher than TDVG's 10.37% return.
TMED
- 1D
- -1.51%
- 1M
- 7.82%
- 6M
- 12.95%
- YTD
- 15.07%
- 1Y
- 36.59%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TDVG
- 1D
- -0.14%
- 1M
- 1.83%
- 6M
- 8.35%
- YTD
- 10.37%
- 1Y
- 17.04%
- 3Y*
- 15.25%
- 5Y*
- 10.10%
- 10Y*
- —
TMED vs. TDVG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
TMED T. Rowe Price Health Care ETF | 15.07% | 19.49% |
TDVG T. Rowe Price Dividend Growth ETF | 10.37% | 8.39% |
Correlation
The correlation between TMED and TDVG is 0.55, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.55 |
Correlation (All Time) Calculated using the full available price history since Jun 12, 2025 | 0.56 |
The correlation between TMED and TDVG has been stable across timeframes, ranging from 0.55 to 0.56 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TMED vs. TDVG — Risk / Return Rank
TMED
TDVG
TMED vs. TDVG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and T. Rowe Price Dividend Growth ETF (TDVG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TMED | TDVG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.22 | ||
| Sortino ratioReturn per unit of downside risk | +0.35 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.32 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 3.31 | 2.37 | +0.94 |
| Martin ratioReturn relative to average drawdown | 11.19 | 9.75 | +1.44 |
Loading charts...
Drawdowns
TMED vs. TDVG - Drawdown Comparison
The maximum TMED drawdown since its inception was -11.11%, smaller than the maximum TDVG drawdown of -19.20%. Use the drawdown chart below to compare losses from any high point for TMED and TDVG.
Loading charts...
Drawdown Indicators
| TMED | TDVG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -11.11% | -19.20% | +8.09% |
Max Drawdown (1Y)Largest decline over 1 year | -11.11% | -7.24% | -3.87% |
Max Drawdown (3Y)Largest decline over 3 years | — | -14.02% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -19.20% | — |
Current DrawdownCurrent decline from peak | -3.34% | -0.38% | -2.96% |
Average DrawdownAverage peak-to-trough decline | -2.39% | -3.69% | +1.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.31% | 1.75% | +1.56% |
Volatility
TMED vs. TDVG - Volatility Comparison
T. Rowe Price Health Care ETF (TMED) has a higher volatility of 5.12% compared to T. Rowe Price Dividend Growth ETF (TDVG) at 1.87%. This indicates that TMED's price experiences larger fluctuations and is considered to be riskier than TDVG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TMED | TDVG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.12% | 1.87% | +3.25% |
Volatility (6M)Calculated over the trailing 6-month period | 14.15% | 7.44% | +6.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.53% | 9.70% | +8.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.22% | 13.91% | +4.31% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.22% | 13.85% | +4.37% |
TMED vs. TDVG - Expense Ratio Comparison
TMED has a 0.44% expense ratio, which is lower than TDVG's 0.50% expense ratio.
Dividends
TMED vs. TDVG - Dividend Comparison
TMED's dividend yield for the trailing twelve months is around 0.47%, less than TDVG's 0.97% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
TDVG T. Rowe Price Dividend Growth ETF | 0.97% | 1.00% | 1.06% | 1.31% | 1.15% | 0.80% | 0.40% |
TMED T. Rowe Price Health Care ETF | 0.47% | 0.54% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
TMED and TDVG have a correlation of 0.55, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TMED has higher volatility (5.12%) compared to TDVG (1.87%). In terms of maximum drawdown, TMED dropped -11.11% vs TDVG's -19.20%.
On 1-year performance, TMED leads with 36.59% vs 17.04% for TDVG. On fees, TMED is cheaper at 0.44% per year. On volatility, TDVG has been the lower-risk option at 1.87%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, TMED has performed better with a 36.59% return vs 17.04%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
TMED is cheaper with a 0.44% expense ratio, compared with 0.50% for TDVG.
TDVG has the higher dividend yield at 0.97%, compared with 0.47% for TMED.
TMED is categorized as Health & Biotech Equities, while TDVG is Large Cap Growth Equities. Their fees differ too: 0.44% for TMED and 0.50% for TDVG.
TMED currently has the higher Sharpe Ratio (1.98 vs 1.77), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TMED and TDVG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer